Clinical Trials Logo
  1. Home
  2. Glaucoma, Neovascular
  3. NCT01922154

Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma

Glaucoma, Neovascular Clinical Trial

Official title:
Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma

Clinical Trial Summary

To evaluate the effects of intravitreal ranibizumab (IVR) as adjunctive treatment for trabeculectomy with mitomycin C (TMC) in neovascular glaucoma (NVG).

Clinical Trial Description

This is a prospective study of 15 consecutive eyes from 14 patients (One patients had NVG in both eyes at presentation.) with NVG presented at the Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand between December 2008 and December 2009. Each eye received IVR (0.5 mg/0.05 ml) 1 week before TMC. Trabeculectomy was performed with fornix-based conjunctival flap method. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01922154
Study type Interventional
Source Siriraj Hospital
Contact
Status Completed
Phase Phase 4
Start date February 2009
Completion date December 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT01908816 - An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. Phase 3
Completed NCT03639675 - Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied Phase 3
Not yet recruiting NCT02914626 - Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study Phase 3
Not yet recruiting NCT05593354 - MicroPulse TLT - UK Study
Completed NCT03187418 - Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma N/A
Completed NCT02647515 - Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma Phase 4
Enrolling by invitation NCT04381611 - INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Completed NCT04215575 - Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases N/A
Completed NCT04214847 - The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases N/A
Recruiting NCT03648814 - Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT N/A
Completed NCT02396316 - Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients Phase 3